From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Kiran Musunuru(Harvard University), Alanna Strong(Translational Therapeutics (United States)), Maria Frank-Kamenetsky(Alnylam Pharmaceuticals (United States)), Noemi E Lee(Harvard University), Tim Ahfeldt(Harvard University), Katherine V. Sachs(Translational Therapeutics (United States)), Xiaoyu Li(Translational Therapeutics (United States)), Hui Li(Translational Therapeutics (United States)), Nicolas Kuperwasser(Harvard University), Vera M. Ruda(Harvard University), James P. Pirruccello(Broad Institute), Brian Muchmore(National Institutes of Health), Ludmila Prokunina‐Olsson(National Institutes of Health), Jennifer L. Hall(Broad Institute), Eric E. Schadt(Sage Bionetworks), Carlos R. Morales(McGill University), Sissel Lund‐Katz(Children's Hospital of Philadelphia), Michael C. Phillips(Children's Hospital of Philadelphia), Jamie Wong(Alnylam Pharmaceuticals (United States)), William Cantley(Alnylam Pharmaceuticals (United States)), Timothy Racie(Alnylam Pharmaceuticals (United States)), Kenechi G. Ejebe(Broad Institute), Marju Orho‐Melander(Lund University), Olle Melander(Lund University), Victor Koteliansky(Alnylam Pharmaceuticals (United States)), Kevin Fitzgerald(Alnylam Pharmaceuticals (United States)), Ronald M. Krauss, Chad A. Cowan(Broad Institute), Sekar Kathiresan(Broad Institute), Daniel J. Rader(Translational Therapeutics (United States))
Cited by 1,184Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis